Subscribe

|Videos|June 27, 2023

Visibility and Risk Management with Overhaul

Author(s)Amy Shortman

Amy Shortman, Overhaul, explains the importance of visibility for risk management and compliance issues when navigating the supply chain and highlights solutions to support life sciences.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Related Content

How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins

ByShana Wray, FourKites

December 15th 2025

Trade & Channel Strategies 2025: Inside Pharma’s Turning Point

ByNicholas Saraceno, Editor,Bill Roth, IntegriChain

December 15th 2025

Pharmaceutical Commerce

Trade & Channel Strategies 2025: Topics of Interest

ByNicholas Saraceno, Editor,Cheryl Allen, BS Pharm, MBA, Curatio Scientia Advisors,Nicholas Jacobus

December 12th 2025

Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial

ByNicholas Saraceno, Editor

December 12th 2025

Trade & Channel Strategies 2025: DSCSA Status Following Implementation

ByNicholas Saraceno, Editor

December 11th 2025

Trending on Pharmaceutical Commerce

The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies

Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap

Trade & Channel Strategies 2025: Inside Pharma’s Turning Point

Working with the Middle

A 'Beautiful Fake': Pharma Fraudsters Upping Their Game

© 2025 MJH Life Sciences^®

All rights reserved.